A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Clinical trial NCT00404963 · COMPLETED

Trial details

NCT number: NCT00404963
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2006-10-01
Primary completion: 2007-05-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.